title: Pulmonary hypertension update from CHEST 2012.
authors.affiliation: Division of Pulmonary, Allergy, Critical Care, Occupational and Sleep Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. tlahm@iupui.edu
authors.forename: T
authors.initials: T
authors.lastname: Lahm
mesh_terms: D002317:Cardiovascular Agents / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D003935:Diagnostic Techniques, Cardiovascular; D019468:Disease Management; D011464:Epoprostenol / Q000494:pharmacology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011720:Pyrazoles / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D012129:Respiratory Function Tests; D013449:Sulfonamides / Q000494:pharmacology; D035703:Therapies, Investigational; D018497:Ventricular Dysfunction, Right / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
chemical_list: D002317:Cardiovascular Agents; D011720:Pyrazoles; D011743:Pyrimidines; D013449:Sulfonamides; D011464:Epoprostenol; C542595:riociguat; C533860:macitentan